๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Synthesis and NMD A Antagonistic Properties of the Enantiomers of 4-(3-phosphonopropyl)piperazine-2-carboxylic acid (CPP) and of the unsaturated analogue (E)-4-(3-phosphonoprop-2-enyl)piperazine-2-carboxylic acid (CPP-ene)

โœ Scribed by Bernard Aebischer; Peter Frey; Hans-Peter Haerter; Paul L. Herrling; Werner Mueller; Henry J. Olverman; Jeffrey C. Watkins


Publisher
John Wiley and Sons
Year
1989
Tongue
German
Weight
552 KB
Volume
72
Category
Article
ISSN
0018-019X

No coin nor oath required. For personal study only.

โœฆ Synopsis


The ( R )and (S)-enantiomers of 4-(3-phosphonopropyl)piperazine-2-carboxylic acid (D-and L-CPP, resp.; 15 and 16, resp.), and of its unsaturated analogue (E)-4-(3-phosphonoprop-2-enyl)piperazine-2-carboxylic acid (D-and L-CPP-ene, resp.; 13 and 14, resp.) were prepared. The absolute configuration of the enantiomers was determined by a chemical correlation of the menthyl ester 7 with o-asparagine. The affinity of these derivatives for the NMDA receptor was determined by displacement of [3H]CPP in rat cerebral cortical membranes. In two functional tests (the frog hemisected spinal cord preparation and the sodium efflux test from rat brain slices), o-CPP-ene appears to be the most potent, enantiomerically pure, competitive NMDA antagonist known to date. ') CPP is the abbreviation of the name 3-(2-carboxypiperazin-4-yl)propyl-1 -phosphonic acid that is currently used in the literature. We prefer the nomenclature employed by Chemical Abstracts that considers the carboxylic-acid moiety as the principal group.


๐Ÿ“œ SIMILAR VOLUMES


Anticonvulsant activity of the NMDA anta
โœ Smita Patel; Astrid G. Chapman; Joanne L. Graham; Brian S. Meldrum; Peter Frey ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 775 KB

D.(-)4.(3-phosphonopropyl)piperazine-2-carboxylic acid (D-CPP) and its unsaturated analogue (D(-)(E).4-(3.phosphonoprop-2enyl) piperazine-2-carboxylic acid (D-CPPene) have been administered to DBA/2 mice (intracerebroventricularly, i.c.v., intraperitoneally, i.p., and orally, p.o.) and to photosensi